Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

17.15
Delayed Data
As of Aug 28
 -0.08 / -0.46%
Today’s Change
9.00
Today|||52-Week Range
24.82
+6.92%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close17.23
Today’s open17.08
Day’s range16.64 - 17.64
Volume111,439
Average volume (3 months)241,626
Market cap$694.1M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+86.49%
Earnings growth (this year)-53.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.41%
P/E ratioNM
Price/Sales52.89
Price/Book9.09

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc+0.40+3.17%
RVNCRevance Therapeutics...-0.01-0.03%
ARNAArena Pharmaceutical...+0.06+2.26%
SGNTSagent Pharmaceutica...+0.17+0.86%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.5M
Annual profit (last year)-$16.4M
Net profit margin-172.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts

Partner Offers